Correction: Predictive biomarkers for disease sensitivity in lymphoma – the holy grail for HDAC inhibitors?

Detalles Bibliográficos
Autor principal: Eyre, Toby A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2019
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6422189/
https://www.ncbi.nlm.nih.gov/pubmed/30899436
http://dx.doi.org/10.18632/oncotarget.26767

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6422189/
https://www.ncbi.nlm.nih.gov/pubmed/30899436
http://dx.doi.org/10.18632/oncotarget.26767

Ejemplares similares